 |
|
|
Personnel:Research - Personal - Prem Pais |
|
| |
|
|
|
|
 |
Prem Pais
Head, Division of Clinical Trials, St. John’s Research Institute
Dean,
St. John's Medical College
Professor of Medicine,
St. John's Medical College Hospital
|
 |
Unit/Division |
| |
|
Division of Clinical Trials |
|
Research Interests |
| |
|
Clinical Trials |
| |
|
Cardiovascular epidemiology |
|
Degrees |
| |
|
MBBS, 1970, St Johns Medical College ,Bangalore |
| |
|
MD (Medicine), 1974, Delhi University |
|
Recent Publications |
| |
|
The Indian Polycap Study (TIPS). Effects of a polypill (Polycap) on risk factors in middle aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomized trial. Lancet 2009. Online March 30, 2009 |
| |
|
Denis Xavier, Prem Pais, PJ Devereaux, Changchun Xie, D Prabhakaran, K Srinath Reddy, Rajeev Gupta, Prashant Joshi, Prafulla Kerkar, S Thanikachalam, KK Haridas, TM Jaison, Sudhir Naik, AK Maity, Salim Yusuf on behalf of the CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008 Apr 26; 371(9622):1435-42. |
| |
|
Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.POISE Study Group, The Lancet, Volume 371, Issue 9627, Pages 1839 - 1847, 31 May 2008 |
| |
|
Joshi P, Islam S, Pais P, Reddy S, Prabhakaran D, Kazmi K et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries JAMA 2007; 297:286-294. |
| |
|
Yusuf S, Mehta S.R, Xie C, Ahmed R.J, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction and strokes in patients with acute myocardial infarction presenting with ST segment elevation. JAMA 2005; 293:427-436. |
| |
|
Prem Pais, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayaprakash S, Nayak P R & Yusuf A. Risk factors for acute myocardial infarction in Indians: a case control study. Lancet 1996;348:358 -364 |
| |
|
Pais P. Preventing ischaemic heart disease in developing countries. Evid Based Cardiovasc Med 2006;10:85-88 |
| |
|
Pais PS. Early intervention and prevention of myocardial infarction. J Hypertens Suppl.2006;14:S25-30 |
| |
|
Gupta R, Misra A, Pais P, Rastogi P & Gupta VP. Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factors. Int J Cardiol. 2006;108:291-300. |
| |
|
Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D. Pais P et al. for the CREATE Trial Group Investigators. Effects of Reviparin, a low molecular weight heparin, on mortality, reinfarction and strokes in patients with acute myocardial infarction presenting with ST segment elevation. JAMA 2005;293:427-436. |
| |
|
Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D. et al. for the CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005;293:437-446. |
| |
|
Prabhakaran D, Yusuf S, Mehta S, Pogue J, Avezum A, Budaj A, Cerumzynski L, Flather M, Fox K, Hunt D, Lisheng L, Keltai M, Parkhomenko A, Pais P, Reddy S, Ruda M, Hiquing T, Jun Z. Two year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2. Indian Heart J 2005;57:217-225. |
|
|
|
|
